UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 736

Sortiert nach

Improved template – ion exchange synthesis of Cu-nanostructured molecular sieves

Microporous and mesoporous materials, 2019-08, Vol.284, p.410-420

2019

Link zum Volltext

Verfügbarkeit prüfen

Copper-containing spherical mesoporous silicates prepared by template-ion exchange: A multitechnique characterization and oxidation properties

Microporous and mesoporous materials, 2012-03, Vol.151, p.2-12

2012

Link zum Volltext

Verfügbarkeit prüfen

Oxidation of olefins employing mesoporous molecular sieves modified with copper

Applied catalysis. A, General, 2013-07, Vol.462-463, p.8-14

2013

Link zum Volltext

Verfügbarkeit prüfen

Catalytic performance of V-MCM-41 nanocomposites in liquid phase limonene oxidation: Vanadium leaching mitigation

Microporous and mesoporous materials, 2021-02, Vol.311, p.110678, Article 110678

2021

Link zum Volltext

Verfügbarkeit prüfen

Preparation, characterization, and application of nano‐FeOx/Al2O3/cordierite monolithic catalysts for heterogeneous dark Fenton reaction

Journal of chemical technology and biotechnology (1986), 2020-11, Vol.95 (11), p.2868-2878

2020

Link zum Volltext

Verfügbarkeit prüfen

H2O2 based α-pinene oxidation over Ti-MCM-41. A kinetic study

Journal of molecular catalysis. A, Chemical, 2011-08, Vol.347 (1-2), p.1-7

2011

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed refractory multiple myeloma

Leukemia, 2010-05, Vol.24 (5), p.1037-1042

2010

Link zum Volltext

Verfügbarkeit prüfen

Selective oxidation of ethanol on V-MCM-41 catalysts

Catalysis today, 2020-10, Vol.356, p.464-470

2020

Link zum Volltext

Verfügbarkeit prüfen

Vanadium Supported on Titanium Pillared Montmorillonite Clay for the Selective Catalytic Oxidation of Benzyl Alcohol

Topics in catalysis, 2022-09, Vol.65 (13-16), p.1373-1381

2022

Link zum Volltext

Verfügbarkeit prüfen

Limonene oxyfunctionalization over Cu-modified silicates employing hydrogen peroxide and t-Butyl hydroperoxide: Reaction pathway analysis

Molecular catalysis, 2020-02, Vol.481, p.110234, Article 110234

2020

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneous Fenton reaction for the treatment of ACE in residual waters of pharmacological origin using Fe-SBA-15 nanocomposites

Molecular catalysis, 2020-02, Vol.481, p.110239, Article 110239

2020

Link zum Volltext

Verfügbarkeit prüfen

Nature of active vanadium nanospecies in MCM-41 type catalysts for olefins oxidation

Materials chemistry and physics, 2016-06, Vol.175, p.172-179

2016

Link zum Volltext

Verfügbarkeit prüfen

Votata a llengua nosta: Baroque Naples and The Language Question

Quaderni d'italianistica, 2021-01, Vol.42 (2), p.109-140

Canepa, Nancy L.

2021

Link zum Volltext

Verfügbarkeit prüfen

Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes

Blood, 1989-01, Vol.73 (1), p.334-339

1989

Link zum Volltext

Verfügbarkeit prüfen

Mesoporous Silicates with Spherical Morphology Modified with Vanadium Highly Active in Oxidation of Cyclohexene with H2O2

Topics in catalysis, 2011-03, Vol.54 (1-4), p.160-169

2011

Link zum Volltext

Verfügbarkeit prüfen

PO023 High dose of r-EPO (40,000 IU) once a week is highly effective in a selected cohort of MDS patients with basal EPO level <250mu/ml, IPSS score ≤1.5 and low transfusional need

Leukemia research, 2007, Vol.31, p.S140-S140

2007

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse

Bone marrow transplantation (Basingstoke), 2002-11, Vol.30 (9), p.579-585

2002

Link zum Volltext

Verfügbarkeit prüfen

First Line Therapy with Fludarabine Combinations in 42 Patients with Either Post Myelodysplastic Syndrome or Therapy Related Acute Myeloid Leukaemia

Leukemia & lymphoma, 2001, Vol.40 (3-4), p.305-313

2001

Link zum Volltext

Verfügbarkeit prüfen

Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation

Haematologica (Roma), 2001-07, Vol.86 (7), p.706

2001

Link zum Volltext

Verfügbarkeit prüfen

Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients

Journal of experimental & clinical cancer research, 2002-12, Vol.21 (4), p.481

2002

Link zum Volltext

Verfügbarkeit prüfen

Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens

Journal of experimental & clinical cancer research, 2001-06, Vol.20 (2), p.165

2001

Link zum Volltext

Verfügbarkeit prüfen

First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease

European journal of haematology, 1998-09, Vol.61 (3), p.197-203

1998

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide-induced cardiotoxicity in multiple myeloma patients: An underestimated but clinically relevant issue

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18544-e18544

2010

Link zum Volltext

Verfügbarkeit prüfen

Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?

Journal of experimental & clinical cancer research, 2001-09, Vol.20 (3), p.351-358

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 736

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(582)
Mit Volltextzugriff
(637)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Improved template – ion exchange synthesis of Cu-nanostructured molecular sieves

Copper-containing spherical mesoporous silicates prepared by template-ion exchange: A multitechnique characterization and oxidation properties

Oxidation of olefins employing mesoporous molecular sieves modified with copper

Catalytic performance of V-MCM-41 nanocomposites in liquid phase limonene oxidation: Vanadium leaching mitigation

Preparation, characterization, and application of nano‐FeOx/Al2O3/cordierite monolithic catalysts for heterogeneous dark Fenton reaction

H2O2 based α-pinene oxidation over Ti-MCM-41. A kinetic study

Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed refractory multiple myeloma

Selective oxidation of ethanol on V-MCM-41 catalysts

Vanadium Supported on Titanium Pillared Montmorillonite Clay for the Selective Catalytic Oxidation of Benzyl Alcohol

Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide

Limonene oxyfunctionalization over Cu-modified silicates employing hydrogen peroxide and t-Butyl hydroperoxide: Reaction pathway analysis

Heterogeneous Fenton reaction for the treatment of ACE in residual waters of pharmacological origin using Fe-SBA-15 nanocomposites

Nature of active vanadium nanospecies in MCM-41 type catalysts for olefins oxidation

Votata a llengua nosta: Baroque Naples and The Language Question

Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes

Mesoporous Silicates with Spherical Morphology Modified with Vanadium Highly Active in Oxidation of Cyclohexene with H2O2

PO023 High dose of r-EPO (40,000 IU) once a week is highly effective in a selected cohort of MDS patients with basal EPO level <250mu/ml, IPSS score ≤1.5 and low transfusional need

Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse

First Line Therapy with Fludarabine Combinations in 42 Patients with Either Post Myelodysplastic Syndrome or Therapy Related Acute Myeloid Leukaemia

Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation

Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients

Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens

First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease

Thalidomide-induced cardiotoxicity in multiple myeloma patients: An underestimated but clinically relevant issue

Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?

Suchergebnisse filtern